Novo CEO Doustdar On What’s New For Ozempic, Wegovy, GLP-1s, Obesity

1. Forbes FIRST 1h ago Novo CEO Doustdar On What’s New For Ozempic, Wegovy, GLP-1s, Obesity

   Novo president and chief executive officer Mike Doustdar talked about Ozempic, Wegovy, new GLP-1 medications, weight loss and obesity and the company's new rebrand

Related stories

Sports Viral video captures hotel brawl between MMA stars Dvalishvili, Nurmagomedov 5 sources Business House Republicans consider issuing subpoena to Nvidia CEO Jensen Huang 28 sources Sports Hawkins, Ponga and Waaka win Golden Boot awards 2 sources Entertainment Claes Bang, Emma Mackey, Vicky Krieps and More Join Marion Cotillard in Marrakech Jury 2 sources

← Front page